176 related articles for article (PubMed ID: 30681172)
1. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma.
Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
Aliment Pharmacol Ther; 2019 Mar; 49(5):589-598. PubMed ID: 30681172
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study.
Kim JH; Bang YJ; Park BJ; Yoo T; Kim CW; Kim TY; Heo DS; Lee HS; Kim NK
Jpn J Cancer Res; 2002 May; 93(5):471-7. PubMed ID: 12036441
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
Engels EA; Cho ER; Jee SH
Lancet Oncol; 2010 Sep; 11(9):827-34. PubMed ID: 20688564
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
[TBL] [Abstract][Full Text] [Related]
5. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.
Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
Aliment Pharmacol Ther; 2019 Feb; 49(3):331-339. PubMed ID: 30592071
[TBL] [Abstract][Full Text] [Related]
6. Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan.
Kamiza AB; Su FH; Wang WC; Sung FC; Chang SN; Yeh CC
BMC Cancer; 2016 Nov; 16(1):861. PubMed ID: 27821099
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study.
Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
Hepatology; 2016 Mar; 63(3):721-30. PubMed ID: 26662347
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
9. The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.
Huang CE; Yang YH; Chen YY; Chang JJ; Chen KJ; Lu CH; Lee KD; Chen PC; Chen CC
J Viral Hepat; 2017 Oct; 24(10):885-894. PubMed ID: 28375587
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B and C virus infection and risk of lymphoid malignancies: A population-based cohort study (JPHC Study).
Abe SK; Inoue M; Sawada N; Iwasaki M; Shimazu T; Yamaji T; Sasazuki S; Tanaka Y; Mizokami M; Tsugane S;
Cancer Epidemiol; 2015 Aug; 39(4):562-6. PubMed ID: 26149122
[TBL] [Abstract][Full Text] [Related]
11. Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Britton JA; Khan AE; Rohrmann S; Becker N; Linseisen J; Nieters A; Kaaks R; Tjønneland A; Halkjaer J; Severinsen MT; Overvad K; Pischon T; Boeing H; Trichopoulou A; Kalapothaki V; Trichopoulos D; Mattiello A; Tagliabue G; Sacerdote C; Peeters PH; Bueno-de-Mesquita HB; Ardanaz E; Navarro C; Jakszyn P; Altzibar JM; Hallmans G; Malmer B; Berglund G; Manjer J; Allen N; Key T; Bingham S; Besson H; Ferrari P; Jenab M; Boffetta P; Vineis P; Riboli E
Haematologica; 2008 Nov; 93(11):1666-77. PubMed ID: 18835833
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition.
Khan AE; Gallo V; Linseisen J; Kaaks R; Rohrmann S; Raaschou-Nielsen O; Tjønneland A; Johnsen HE; Overvad K; Bergmann MM; Boeing H; Benetou V; Psaltopoulou T; Trichopoulou A; Masala G; Mattiello A; Grioni S; Tumino R; Vermeulen RC; Peeters PH; Bueno-de-Mesquita HB; Ros MM; Lund E; Ardanaz E; Chirlaque MD; Jakszyn P; Larrañaga N; Losada A; Becker N; Nieters A; Martínez-García C; Agren A; Hallmans G; Berglund G; Manjer J; Allen NE; Key TJ; Bingham S; Khaw KT; Slimani N; Ferrari P; Boffetta P; Norat T; Vineis P; Riboli E;
Haematologica; 2008 Jun; 93(6):842-50. PubMed ID: 18443270
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China.
Wang C; Xia B; Ning Q; Zhao H; Yang H; Zhao Z; Wang X; Wang Y; Yu Y; Zhang Y
Ann Hematol; 2018 Mar; 97(3):453-457. PubMed ID: 29188315
[TBL] [Abstract][Full Text] [Related]
14. Association of chronic hepatitis B virus infection with age-related macular degeneration.
Wu CM; Su FH; Wang WC; Lin CP; Kamiza AB; Chang SN; Yeh CC
Acta Ophthalmol; 2019 Aug; 97(5):e713-e718. PubMed ID: 30690913
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.
Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM
Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583
[TBL] [Abstract][Full Text] [Related]
17. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
[TBL] [Abstract][Full Text] [Related]
18. 13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan.
Chen YC; Su YC; Li CY; Hung SK
BMC Nephrol; 2015 Jul; 16():110. PubMed ID: 26199000
[TBL] [Abstract][Full Text] [Related]
19. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
Hwang JP; Suarez-Almazor ME; Cantor SB; Barbo A; Lin HY; Ahmed S; Chavez-MacGregor M; Donato-Santana C; Eng C; Ferrajoli A; Fisch MJ; McLaughlin P; Simon GR; Rondon G; Shpall EJ; Lok AS
Cancer; 2017 Sep; 123(17):3367-3376. PubMed ID: 28518219
[TBL] [Abstract][Full Text] [Related]
20. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ
World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
